LINCOLN NATIONAL CORP
For the period ended Jun 30, 2025. Filed Jul 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Group Protection
Details underlying the results for Group Protection (in millions) were as follows:
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Operating Revenues | ||||
| Insurance premiums | $1,386 | $1,298 | $2,757 | $2,583 |
| Net investment income | 94 | 88 | 183 | 173 |
| Other revenues (1) | 58 | 55 | 119 | 111 |
| Total operating revenues | 1,538 | 1,441 | 3,059 | 2,867 |
| Operating Expenses | ||||
| Benefits | 1,017 | 1,032 | 2,082 | 2,062 |
| Interest credited | 1 | 1 | – | 2 |
| Policyholder liability remeasurement (gain) loss | (104) | (124) | (174) | (191) |
| Commissions and other expenses | 405 | 367 | 804 | 728 |
| Total operating expenses | 1,319 | 1,276 | 2,712 | 2,601 |
| Income (loss) from operations before taxes | 219 | 165 | 347 | 266 |
| Federal income tax expense (benefit) | 46 | 35 | 73 | 56 |
| Income (loss) from operations | $173 | $130 | $274 | $210 |
(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Income (Loss) from Operations by Product Line | ||||
| Life | $41 | $10 | $50 | $19 |
| Disability | 135 | 122 | 229 | 194 |
| Dental | (3) | (2) | (5) | (3) |
| Income (loss) from operations | $173 | $130 | $274 | $210 |
Comparison of the Three and Six Months Ended June 30, 2025 to 2024
Higher insurance premiums due to growth in business in force and persistency.
Higher net investment income, net of interest credited, driven by growth in business in force.
The increase in income from operations was partially offset by the following:
Higher commissions and other expenses due to incentive compensation as a result of production performance.
Higher benefits, net of policyholder liability remeasurement gain, driven by less favorable claims experience than expected and growth in business in force, partially offset by lower incidence and claims severity in our life business and lower incidence in our disability business.
For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2024 Form 10-K.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” in our 2024 Form 10-K. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2024 Form 10-K.
Insurance Premiums
Details underlying insurance premiums (in millions) were as follows:
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Insurance Premiums by Product Line | ||||
| Life | $542 | $502 | $1,084 | $1,001 |
| Disability | 798 | 750 | 1,581 | 1,490 |
| Dental | 46 | 46 | 92 | 92 |
| Total insurance premiums | $1,386 | $1,298 | $2,757 | $2,583 |
| Sales by Product Line | ||||
| Life | 104 | 81 | $205 | $167 |
| Disability | 70 | 74 | 118 | 125 |
| Dental | 13 | 6 | 21 | 14 |
| Total sales | $187 | $161 | $344 | $306 |
Premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products. Generally, we have higher sales during the fourth quarter of the year.
Net Investment Income
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net Investment Income | ||||
| Fixed maturity AFS securities, mortgage loans on real estate | ||||
| and other, net of investment expenses | $72 | $69 | $143 | $138 |
| Surplus investments (1) | 22 | 19 | 40 | 35 |
| Total net investment income | $94 | $88 | $183 | $173 |
(1)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Benefits, Interest Credited and Policyholder Liability Remeasurement (Gain) Loss
Details underlying benefits, interest credited, policyholder liability remeasurement (gain) loss (in millions) and loss ratios by product line were as follows:
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Benefits, Interest Credited and Policyholder | ||||
| Liability Remeasurement (Gain) Loss by | ||||
| Product Line | ||||
| Life | $364 | $379 | $772 | $758 |
| Disability | 513 | 495 | 1,062 | 1,044 |
| Dental | 37 | 35 | 74 | 71 |
| Total benefits, interest credited and policyholder | ||||
| liability remeasurement (gain) loss | $914 | $909 | $1,908 | $1,873 |
| Loss Ratios by Product Line | ||||
| Life | 67.2% | 75.6% | 71.2% | 75.8% |
| Disability | 64.2% | 65.9% | 67.1% | 70.0% |
| Dental | 80.4% | 78.9% | 79.7% | 77.7% |
| Total | 65.9% | 70.1% | 69.2% | 72.5% |
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.
| For the ThreeMonths Ended June 30, | For the Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Commissions and Other Expenses | ||||
| Commissions | $139 | $113 | $272 | $222 |
| General and administrative expenses | 227 | 226 | 449 | 435 |
| Taxes, licenses and fees | 34 | 33 | 72 | 70 |
| Other | 2 | 1 | 2 | 2 |
| Total expenses incurred | 402 | 373 | 795 | 729 |
| DAC deferrals | (35) | (42) | (67) | (71) |
| Total expenses recognized before amortization | 367 | 331 | 728 | 658 |
| DAC and other intangible amortization | 38 | 36 | 76 | 70 |
| Total commissions and other expenses | $405 | $367 | $804 | $728 |
| DAC Deferrals | ||||
|---|---|---|---|---|
| As a percentage of insurance premiums | 2.5% | 3.2% | 2.4% | 2.7% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.